×

Loading...
Ad by
  • 最优利率和cashback可以申请特批,好信用好收入offer更好。请点链接扫码加微信咨询,Scotiabank -- Nick Zhang 6478812600。
Ad by
  • 最优利率和cashback可以申请特批,好信用好收入offer更好。请点链接扫码加微信咨询,Scotiabank -- Nick Zhang 6478812600。

以色列研究了10万新冠患者,发现辉瑞新冠药Paxlovid对65岁以下的人无效。

The new study likely renews questions about the United States' use of Paxlovid, which has become the go-to treatment due to its at-home convenience.
Report

Replies, comments and Discussions:

  • 枫下家园 / 医药保健 / 以色列研究了10万新冠患者,发现辉瑞新冠药Paxlovid对65岁以下的人无效。
    The new study likely renews questions about the United States' use of Paxlovid, which has become the go-to treatment due to its at-home convenience.
    • 研究人员发现,感染后不久给予 Paxlovid 可使 65 岁及以上人群的住院率降低约 75%。这与早期用于在美国和其他国家批准该药物的结果一致。 +1
    • 这研究结果你信吗?
    • 不信
    • 不信, +2
      65岁以上也没用
    • Wow, USA Today.主流开始分裂了?